SURMODICS INC — Director's Dealing 2021

Dec 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2021-11-30

Reporting Person: BEDOYA JOSE H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-30	Common Stock	M	5576	$21.31	Acquired	28393	Direct
2021-11-30	Common Stock	S	5576	$44.0011	Disposed	22817	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-30	Stock Option (right to buy)	$21.31	M	5576	Disposed	2021-12-03	Common Stock (5576)	Direct

Footnotes

F1: Reflects the weighted average price of 5,576 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on November 30, 2021 with sale prices ranging from $43.50 to $44.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The amount beneficially owned includes 10,610 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.

F3: Fully vested.